KLTO
Klotho Neurosciences, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$56.66M
P/E Ratio
—
EPS
$-0.30
Beta
2.23
52W High
$2.45
52W Low
$0.12
50-Day MA
$0.34
200-Day MA
$0.65
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. The company is headquartered in Omaha, Nebraska.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -198.30% |
| Return on Assets | -71.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.14 |
| Price-to-Book | 5.71 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $108.09M |
| Float | $65.83M |
| % Insiders | 13.09% |
| % Institutions | 4.12% |
Data last updated: 4/8/2026